Luoxin Pharmaceuticals Group Stock Co., Ltd.
002793.SZ - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.31B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $4.31 Billion |
|---|---|
| Enterprise Value | $5.08 Billion |
| Earnings per Share | $-0.27 |
| Beta | 0.25 |
| Outstanding Shares | 1,087,588,486 |
Return
| Return on Equity | -22.20% |
|---|---|
| Return on Assets | -6.92% |
| Return on Invested Capital | -15.60% |
Valuation & Multiples
| P/E Ratio | -16.96 |
|---|---|
| PEG | -14.11 |
| Price to Sales | 2.08 |
| Price to Book Ratio | 4.16 |
| Enterprise Value to Revenue | 2.28 |
| Enterprise Value to EBIT | -25.6 |
| Enterprise Value to Net Income | -21 |
| Total Debt to Enterprise | 0.34 |
| Debt to Equity | 1.56 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Luoxin Pharmaceuticals Group Stock Co., Ltd.
2,962 employees
CEO: Zhenteng Liu
Luoxin Pharmaceuticals Group Stock Co., Ltd. is a Chinese pharmaceutical enterprise, primarily focused on the research, development, manufacture, and commercialization of pharmaceutical products. Headquartered in Linyi, the company offer...